Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial (Q40801133)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial |
scientific article |
Statements
1 reference
Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial (English)
1 reference
Karp JE
1 reference
Merz WG
1 reference
Hendricksen C
1 reference
Laughon B
1 reference
Redden T
1 reference
Bamberger BJ
1 reference
Bartlett JG
1 reference
Saral R
1 reference
Burke PJ
1 reference
1 January 1987
1 reference
1 reference
Identifiers
1 reference